--- title: "ENVISION PHARMA HOLDCO LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b json: https://whiteintel.dev/api/public/dossier/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b identifier: oo:GB-COH-08555733 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # ENVISION PHARMA HOLDCO LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-08555733` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b ## Ownership & control ### Owners / controllers - **ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/528ebfe3-d498-5bea-b63a-d29b2aa865ae - **ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/528ebfe3-d498-5bea-b63a-d29b2aa865ae ### Holdings / subsidiaries - **ELEVATE SCIENTIFIC SOLUTIONS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/d5dfa8da-f889-5625-8903-30eee3c1da4b - **ENVISION PHARMA TRUSTEE LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/ff7e4a8c-c012-5c2d-9ef7-12a8873ca2ea - **ENVISION MARKET ACCESS SOLUTIONS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/813ee9d6-77e4-51b9-b51f-12ff06ee83b3 - **Envision Pharma Inc.** (beneficial owner) — 100% — https://whiteintel.dev/entity/793c62b5-37e0-5fcf-924b-b7f150d63054 - **OKRA HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/f077fc5c-cc4b-546b-b6cb-41c790de8908 - **90TEN GROUP LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/78d2b76f-fbc5-5d8c-ac7a-006bc0077e9c - **ENGAGE SCIENTIFIC SOLUTIONS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/37504808-9d42-51c8-9c1d-b48b42e27b6e - **Excel Scientific Solutions Inc.** (beneficial owner) — 100% — https://whiteintel.dev/entity/894eb7d3-9055-5d54-a7a0-e9d904c41b29 - **CURO CONSULTING LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/a4c3e96a-ce1f-59ad-a235-837b19e2c472 - **ELOQUENT SCIENTIFIC SOLUTIONS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/76f751c0-8275-5a49-a281-861c45234257 - **TOUCH CREATIVE DESIGN LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/63c1b96d-9f14-54d2-8758-59961f0f64a0 - **ENVISION MARKET ACCESS SOLUTIONS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/813ee9d6-77e4-51b9-b51f-12ff06ee83b3 …and **11** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing. ### UBO chain (walk to the ultimate owner) A **13-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `08555733` - **Status:** active - **Type:** ltd - **Incorporated:** 2013-06-04 - **Registered office:** Envision House, 5, North Street, Horsham, West Sussex, RH12 1XQ - **SIC:** 74990 ### Officers - DEUTSCH, Adam Brent, Mr. — director · American · appointed 2024-08-20 - RUDNICK, Stanford Benjamin — director · American · appointed 2024-12-09 - GILLIE, John David — secretary · British · appointed 2013-06-07 · resigned 2021-08-10 - BROWN, Joseph Christopher — director · American · appointed 2013-06-07 · resigned 2021-06-23 - CASWILL, Gregory Spencer — director · British · appointed 2013-06-07 · resigned 2021-12-14 - DUPREE, David Wright — director · American · appointed 2013-06-06 · resigned 2016-07-06 - GILLIE, John David — director · British · appointed 2016-11-10 · resigned 2021-08-10 - HEIM, Margaret — director · American · appointed 2023-02-21 · resigned 2023-08-02 - HEPBURN, Brian Alexander — director · British · appointed 2013-06-07 · resigned 2021-12-14 - HOLLIS KORTH, Joshua — director · American · appointed 2021-12-14 · resigned 2024-11-15 - MILLER III, Howard Collins — director · American · appointed 2023-09-12 · resigned 2024-12-31 - PLUMRIDGE, Scott — director · United States · appointed 2013-06-04 · resigned 2016-07-06 - TRAINOR, Katherine Jeanette — director · American · appointed 2013-08-01 · resigned 2015-03-16 ### Beneficial owners (Persons with Significant Control) - [Alligent Biopharm Consulting (Europe) Limited](https://whiteintel.dev/entity/528ebfe3-d498-5bea-b63a-d29b2aa865ae) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-21 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08555733 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08555733 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **ENVISION PHARMA HOLDCO LIMITED** — https://whiteintel.dev/entity/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **ENVISION PHARMA HOLDCO LIMITED**. Human view: https://whiteintel.dev/entity/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b · Structured JSON: https://whiteintel.dev/api/public/dossier/53d3e1ca-6b6b-5fac-a1ac-83eac48fe52b._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._